How Estrogen Receptor α Responds to Different Signals in Breast Cancer Cells
Author Information
Author(s): Dudek Peter, Picard Didier
Primary Institution: Département de Biologie Cellulaire, Université de Genève, Genève, Switzerland
Hypothesis
The study investigates how different extracellular signals activate estrogen receptor α (ERα) and their impact on gene expression in breast cancer cells.
Conclusion
The type of activating signal influences the target gene selection and regulation by ERα, affecting gene expression patterns relevant to breast cancer progression.
Supporting Evidence
- Estrogen, growth factors, and cAMP elicit distinct ERα-dependent transcriptional responses.
- Tamoxifen can act as an agonist in the presence of certain signals, complicating treatment outcomes.
- The study identified specific gene expression patterns that differ based on the activating signal for ERα.
Takeaway
This study shows that estrogen and other signals can change how a protein called ERα works in breast cancer cells, which can affect how the cancer grows.
Methodology
The study used microarray technology to analyze gene expression in MCF7 breast cancer cells treated with estrogen, growth factors, and cAMP.
Potential Biases
Potential bias may arise from using only one cell line and specific treatment conditions that may not reflect in vivo environments.
Limitations
The study primarily focuses on a single breast cancer cell line, which may not fully represent the complexity of breast cancer in patients.
Participant Demographics
Human MCF7 breast cancer cells were used in the study.
Statistical Information
P-Value
p=0.007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website